UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of July 2017
Commission File No. 00-30082
MERUS LABS INTERNATIONAL
INC.
(Translation of registrant's name into English)
100 Wellington St. West, Suite 2110 P.O. Box
151
Toronto, ON M5K 1H1
(Address of principal
executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F
Form 20-F
[ ] Form 40-F [X]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]
SUBMITTED HEREWITH
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: July 20, 2017
MERUS LABS INTERNATIONAL INC.
/s/ Dr. Michael Bumby
______________________________________________________
Dr.
Michael Bumby
Chief Financial Officer
NOTICE OF CHANGE IN CORPORATE STRUCTURE
Pursuant to Section 4.9 of National Instrument 51-102
Continuous Disclosure Obligations
Item 1 |
Names of the Parties to the Transaction |
| |
Merus Labs International Inc. (Merus) and Norgine B.V. (Norgine). | |
| |
Item 2 |
Description of the Transaction |
| |
Pursuant to a statutory plan of arrangement (the Arrangement) under section 288 of the Business Corporations Act (British Columbia), Norgine acquired all of the issued and outstanding shares of Merus (Shares) and shareholders of Merus received $1.65 per Share in cash. | |
| |
In connection with the Arrangement, the Shares are expected to be delisted from the Toronto Stock Exchange on July 20, 2017. | |
| |
Item 3 |
Effective Date of the Transaction |
| |
The effective date of the Arrangement was July 17, 2017. | |
| |
Item 4 |
Names of Each Party, if Any, that Ceased to be a Reporting Issuer Subsequent to the Transaction and of Each Continuing Entity |
| |
Merus is in the process of applying to cease to be a reporting issuer in each jurisdiction in which Merus is currently a reporting issuer. | |
| |
Item 5 |
Date of the Reporting Issuer's First Financial Year-End Subsequent to the Transaction |
| |
Not applicable. | |
| |
Item 6 |
Periods, Including the Comparative Periods, if Any, of the Interim and Annual Financial Statements Required to be Filed for the Reporting Issuer's First Financial Year Subsequent to the Transaction |
| |
Not applicable. | |
| |
Item 7 |
Documents Filed under NI 51-102 that Describe the Transaction and Where those Documents can be Found in Electronic Format |
| |
Not applicable. |
DATE: July 19, 2017